2008 round-up: The year’s most clicked video and audio podcasts

NutraIngredients-USA is reviewing the year and recapping on which articles generated the most interest amongst you, the readers. Today we look at the video and audio podcasts that sparked the most interest.

Antioxidants come first

Top of the pops was Stephen Daniells’ canvassed views on the use of the term 'antioxidant' at this year’s SupplySide West in Las Vegas. He asked whether the industry is storing up future problems by over-egging their potential. Alex Schauss from AIBMR, Colleen Zammer from Futureceuticals, and Laurent Leduc from Frutarom share their views.

To listen to The pros and cons of antioxidant claims, please click here.

Omega-3 in at number 2

Coming in a close second is Lorraine Heller’s round table discussion about the necessity and challenges of establishing a recommended daily intake (RDI) for omega-3 fatty acids.

Lorraine talks to Dr Alex Richardson from FAB Research, Robert Orr from Ocean Nutrition, GOED, and Jerry Luff from NuMega.

To watch Omega-3 and the need for an RDI, please click here.

Our thoughts from the show floor

Number three on the most watched/ listened to list is our round-up of SupplySide West 2008. Stephen Daniells and Lorraine Heller shared their thoughts on the major take-aways from the ingredients, science and education on offer at the biggest annual event for the North American nutraceutical and functional food industries.

To listen to What NutraIngredients-USA took away from SSW, please click here.

Around we go again

Another round table discussion was the fourth most clicked audiovisual article of the year. Stephen Daniells talked to Cathy Signoret from Cosucra, Dr Julian Stowell from Danisco Sweetners, and Dr Gerard Corthier from France’s INRA about the role of gut bacteria in obesity.

Could probiotics and prebiotics play a role in the battle against the bulge?

To watch Round table: Gut health and obesity, please click here.

Weighting for number 5

Bringing the top 5 to a close is Lorraine Heller’s interview with Kenn Israel, Robinson Pharma’s marketing vice president, about the GlaxoSmithKline petition for weight loss claims to be treated as disease claims, and the potential impact of this on the dietary supplement market.

To watch The drug threat to weight loss supplements, please click here.